Digital therapeutics and lifestyle: the start of a new era in the management of arterial hypertension?

Luis M Ruilope^{1

2

3}, Pedro L Valenzuela³, Alejandro Lucia^{3

4}

Affiliations

¹ Cardiorenal Translational Laboratory, Institute of Research i+12, Hospital Universitario 12 de Octubre, Madrid, Spain.
² CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain.
³ Faculty of Sport Sciences, European University of Madrid, Spain.
⁴ Research Institute of the Hospital Universitario 12 de Octubre (imas12, PaHerg group), Madrid, Spain.

Editorial

Luis M Ruilope et al. Eur Heart J. 2021.

. 2021 Oct 21;42(40):4123-4125.

doi: 10.1093/eurheartj/ehab694.

Luis M Ruilope^{1

2

3}, Pedro L Valenzuela³, Alejandro Lucia^{3

4}

¹ Cardiorenal Translational Laboratory, Institute of Research i+12, Hospital Universitario 12 de Octubre, Madrid, Spain.
² CIBER-CV, Hospital Universitario 12 de Octubre, Madrid, Spain.
³ Faculty of Sport Sciences, European University of Madrid, Spain.
⁴ Research Institute of the Hospital Universitario 12 de Octubre (imas12, PaHerg group), Madrid, Spain.

No abstract available

Comment on

Efficacy of a digital therapeutics system in the management of essential hypertension: the HERB-DH1 pivotal trial.
Kario K, Nomura A, Harada N, Okura A, Nakagawa K, Tanigawa T, Hida E. Kario K, et al. Eur Heart J. 2021 Oct 21;42(40):4111-4122. doi: 10.1093/eurheartj/ehab559. Eur Heart J. 2021. PMID: 34455443 Free PMC article. Clinical Trial.